(Q68015565)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

title

Remarkable improvement of neuropsychiatric symptoms in HIV-infected patients after AZT therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

author name string

M Hollweg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

R R Riedel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

F D Goebel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

U Schick

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

D Naber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

publication date

1 June 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

published in

Klinische Wochenschrift

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

page(s)

409-412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

Azidothymidine and the nervous system

20 September 2019

cites work

1 reference

12 December 2020

Necrotising myopathy and zidovudine

1 reference

12 December 2020

Acute meningo-encephalitis on dose reduction of zidovudine

1 reference

12 December 2020

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

12 December 2020

From the Food and Drug Administration. Update on zidovudine

1 reference

12 December 2020

Neurologic manifestations of AIDS.

1 reference

12 December 2020

A pilot study of low-dose zidovudine in human immunodeficiency virus infection

1 reference

12 December 2020

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

1 reference

12 December 2020

Mitochondrial myopathy caused by long-term zidovudine therapy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01647415

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1921244%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference